Company Data
Avalo Therapeutics Inc.
Ticker
AVTX
Current Price
$15.87 -5.42%
Market Cap
$287.8M
Price Target
Refer to Report
Volume
354.9K
52wk Range
$3.39 - $19.41
Overview
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.